Rationale for treating primary Sjögren's syndrome patients with an anti-CD6 monoclonal antibody (Itolizumab).
about
Immunological and histological evaluation of clinical samples from psoriasis patients treated with anti-CD6 itolizumabImmunological evaluation of rheumatoid arthritis patients treated with itolizumab.Cell surface membrane proteins as personalized biomarkers: where we stand and where we are headed.Biologic treatment in Sjögren's syndrome.Itolizumab - a humanized anti-CD6 monoclonal antibody with a better side effects profile for the treatment of psoriasisRelevance of CD6-Mediated Interactions in the Regulation of Peripheral T-Cell Responses and Tolerance.Itolizumab, a novel anti-CD6 monoclonal antibody: a safe and efficacious biologic agent for management of psoriasis.Unraveling the soul of autoimmune diseases: pathogenesis, diagnosis and treatment adding dowels to the puzzle.Lymphocyte Disturbances in Primary Antiphospholipid Syndrome and Application to Venous Thromboembolism Follow-Up.
P2860
Q33573621-79D74152-8362-4741-A77A-0CDD738D12E1Q37138277-20A89199-0623-45F3-BD93-931CCA1DF7B0Q38138610-94F0BAEA-E625-43B0-8FB4-CC2E6974D910Q38262453-9BFA3072-4D25-4780-A12D-D14B73B99760Q38461733-F842116F-4B47-439F-B9AC-AD475A379037Q38726869-41A26A12-B12A-46ED-9FDF-E11BD03408E5Q39033726-5C066671-BBA5-43BC-9BB7-762BE77FB3B3Q43734009-BD9B9C24-A8ED-4693-9F66-8AE7F7B23BB2Q50640109-6661FD9A-4FD1-441B-AE17-D2778516CA21
P2860
Rationale for treating primary Sjögren's syndrome patients with an anti-CD6 monoclonal antibody (Itolizumab).
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Rationale for treating primary ...... oclonal antibody (Itolizumab).
@en
Rationale for treating primary ...... n anti-CD6 monoclonal antibody
@nl
type
label
Rationale for treating primary ...... oclonal antibody (Itolizumab).
@en
Rationale for treating primary ...... n anti-CD6 monoclonal antibody
@nl
prefLabel
Rationale for treating primary ...... oclonal antibody (Itolizumab).
@en
Rationale for treating primary ...... n anti-CD6 monoclonal antibody
@nl
P2093
P2860
P50
P1433
P1476
Rationale for treating primary ...... oclonal antibody (Itolizumab).
@en
P2093
Christelle Le Dantec
Enrique Montero
Ruby Alonso
Tinhinane Fali
Valérie Devauchelle
P2860
P2888
P304
P356
10.1007/S12026-013-8423-X
P577
2013-07-01T00:00:00Z